The p53 transcription factor has a critical role in cell stress response and in tumor suppression. Wild-type p53 protein is a growth modulator and its inactivation is a critical event in malignant transformation. It has been recently demonstrated that wild-type p53 has developmental and differentiation functions. Indeed an overexpression of p53 in tumor cells induces asymmetrical division avoiding self-renewal of cancer stem cells (CSCs) and instead promoting their differentiation. In this study, 28 human breast carcinomas have been analyzed for expression of wild-type p53 and of a pool of non-clustered homeobox genes. We demonstrated that orthodenticle homolog 1 gene (OTX1) is transcribed in breast cancer. We established that the p53 protein directly induces OTX1 expression by acting on its promoter. OTX1 has been described as a critical molecule for axon refinement in the developing cerebral cortex of mice, and its activity in breast cancer suggests a synergistic function with p53 in CSC differentiation. Wild-type p53 may regulate cellular differentiation by an alternative pathway controlling OTX1 signaling only in breast cancer cells and not in physiological conditions.
Introduction
The mammary gland, unlike most organs that form in a linear way during embryogenesis, develops after puberty.
At puberty ovarian hormones stimulate ductal elongation and the cells involved differentiate into lumen epithelial cells and myoepithelial cells. The ducts remain quiescent until pregnancy. How this control is regulated is not known, but probably involves the orchestration of hormones, morphogens and growth factors (Lewis, 2000; Watabe and Miyazono, 2009) . After its development, the mammary gland passes from linear to cyclical phases. A series of complex transitions lead to lobulo-alveolar differentiation, lactation, involution and gland remodeling. Genetic mutations, mainly in signal transduction genes, have been identified that block or delay these processes.
Recently, new data demonstrate that p53 is implicated in normal cell function, differentiation and development (Levantini et al., 2003; Lin et al., 2005; Riley et al., 2008) . It has a function in the control of asymmetric cell division critical to generate alternative cell fates (Smalley and Ashworth, 2003; Cicalese et al., 2009) . p53 regulates polarity of cell division in mammary stem cells (SCs) . The loss of p53 favors symmetric divisions of cancer stem cells (CSCs), contributing to tumor growth.
In mammals, homeobox genes have critical roles in a variety of developmental processes in the nervous and skeletal systems, in limb and digit formation, and in organogenesis (Eizenberg et al., 1996; Lewis, 2000; Danilova et al., 2008) . One difficulty in understanding the function of individual members of the homeobox family is that little is known about upstream genes that control their expression (Lewis, 2000) . Furthermore, homeotic genes have received attention with respect to mammary gland organogenesis, functional differentiation and cancer (Ford, 1998; Chen and Capecchi, 1999; Cillo et al., 1999; Lewis, 2000; Abate-Shen, 2002; Argiropoulos and Humphries, 2007) . For these reasons, the expression of a pool of non-clustered homeobox genes belonging to the muscle segment homeobox (MSX), empty spiracles homeobox (EMX) and orthodenticle homeobox (OTX) families was investigated in human breast cancer. We showed a statistically significant level of co-expression of p53 and orthodenticle homolog 1 gene (OTX1) in all samples (r ¼ 0.864 significantly different from zero). We demonstrated with in vivo and in vitro experiments the direct regulation of OTX1 by p53. The role of p53 in directing SCs into symmetrical or asymmetrical division could involve the activation of the differentiation function of OTX1.
We detected the increase of OTX1 and p53 gene expression levels in rodent CSCs, when induced to differentiate.
Results
A pool of 33 ductal and lobular breast cancers collected by the pathology department of Varese Hospital (Varese, Italy) were sequenced to evaluate the presence of mutations in p53 (see primer sequences in Supplementary information 1). We found mutations in the p53 DNA-binding domain in three breast cancer samples with a frequency of 9.1 versus 20% reported in literature (Borresen-Dale, 2003) . The mutations found to be heterozygous were p.193H4R, p.195I4T and p.238C4F.
We also found 17 out of 33 (51.5%) tumors to be homozygous for the polymorphism c.412G, which codes for the amino acid R72, 13 out of 33 (39.4%) to be P72R (c.412C4G) and 3 out of 33 (9.1%) to be homozygous for P72 (c.412C). Further analysis in patients' cDNA sequences demonstrated that sample 8, homozygous for P72, and sample 11, homozygous for R72, are respectively heterozygous for polymorphisms c.305G4A and c.836A4G adjacent to 72 on the same stretch of DNA sequence (Carbone et al., 1991; Papadakis et al., 2000; Whibley et al., 2009) . P72 or R72 hemizygosity cannot be excluded in the other patients, as DNA samples are not available (Table 1) .
Quantitative real-time reverse transcriptase PCR (qRT-PCR) was used to evaluate the levels of gene transcription. A total of 28 cases of breast carcinoma were analyzed in parallel with surrounding normal tissue ( Figure 1a) . We excluded from our study three samples, because they were mutated for p53. Alterations in the expression of OTX1 (drosophila) in breast cancer were demonstrated. Tumors showed a higher level of OTX1 expression in comparison with the normal breast tissues, in which we found a basal level of expression. We also observed a statistically significant co-expression of OTX1 and p53 in tumor samples (Figure 1a ), but not in normal breast tissues (data not shown). In tumor tissues, OTX1 and p53 gene expression have a correlation coefficient of r ¼ 0.864 significantly different from zero (t ¼ 8.412), with a probability of P ¼ 1.284E À08 (**Po0.001) (Figure 1b) . The highest and the lowest values were excluded for statistical reasons.
OTX1 expression was confirmed by immunohistochemical analysis. Using the OTX2/OTX1 antibody we showed positivity both for the nuclear (Figure 1c) and/ or the cytoplasmic (Figure 1d ) localization. As OTX2 mRNA has not been detected in any tumors we may consider that the immunoreactivity was due to the presence of OTX1 protein. In p53-mutated cases, no OTX1 positivity was detected (data not shown).
In order to demonstrate the molecular interaction between p53 and OTX1 gene expression, we used an SaOs2 cell line (p53 Tet-On) (Riley et al., 2008) that does not express endogenous p53. The p53 expression in this cell line was induced by adding doxycyline to the culture medium. The expression of p53 at 12, 24 and 48 h (and its absence in control cells), was confirmed by western blot using an anti-p53 antibody (Figure 2a ). To evaluate OTX1 expression levels, we used qRT-PCR and western blot analysis. Both techniques confirmed the expression G2  R72  27  IDC  G3  R72P  29  IDC  G3  R72  31  ILC  G3  R72  33  IDC  G2  R72  35  IDC  G2  R72P  37  IDC  G3  R72  41  IDC  G2  R72P  43  IDC  G3  R72  44  IDC  G2  R72  47  IDC  G2  R72P  49  IDC  G2  R72  50  IDC  G2  R72P  51  IDC  G3  R72  53  IDC  G2  R72P  54  IDC  G2  R72  55  IDC  G2  R72  56  IDC  G2  R72P  57  IDC  G2  R72  58  ILC  G2  R72P  62  IDC  G2  R72  63  IDC  G2  R72P Abbreviations: G1, low-grade; G2, moderate or intermediate grade; G3, high-grade; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; ND, not determined. The numeration is referred to the cDNA p53 sequence accession number NM_000546. Mutation analysis of the p53 gene was performed using direct DNA sequencing of PCR-amplified cDNA. The coding region was amplified using the primer pairs indicated in the supplementary data section (Supplementary Table 1 ). We performed an 'in silico' analysis of an approximate 4.8 Kb CpG island in the 5 0 region of OTX1 gene, looking for p53 regulatory sequences of the OTX1 promoter ( Figure 2c ). The CpG island extends from approximately 3.6 Kb upstream of OTX1 transcription starting site, up to 1.2 Kb downstream to the transcription starting site. The OTX1 transcript contains five exons: the first two represent the 5 0 -UTR, whereas the ATG is located at the beginning of the third exon. It is known that regulatory elements could lie inside introns and exons of UTR mRNA (Gressner et al., 2005) ; indeed the analysis was extended to include the first two exons/introns. Bioinformatic analysis of the region was performed using the MatInspector program by Genomatix (Genomatix Software GmbH, freeware version), looking for transcription factors with In the x-axis are the patient samples and the y-axis the relative gene expression. Tissues from breast carcinoma over two centimeters in diameter were obtained after informed consent from the patients for molecular and cellular analysis. The study was approved by the relevant local ethical committees. For each case, tumor and, when possible, non-neoplastic tissues, were immediately and carefully sampled. Both tissue blocks were divided in two mirror parts, one immediately preserved in RNA later until RNA extraction, the other fixed in formalin and embedded in paraffin to evaluate the suitability of the materials. The RNA was extracted with RNeasy Fibrous Tissue mini Kit from Qiagen (Valencia, CA, USA). Equal amounts (1 mg) of total RNA from each sample were reverse transcribed using random primers (hexamers), according to the protocol of High Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA, USA). qRT-PCR was performed with TaqMan technology in an ABI Prism 7000 apparatus (Applied Biosystems). Human p53 and human OTX1 gene expression were studied using Applied Biosystems assays. Beta-actin was used as a housekeeping gene. A relative quantitative analysis was performed using the 2 ÀDDCt method. In adjacent normal tissues, there is no correlation between the expression levels of OTX1 and p53 (data not shown), (b) whereas in tumor tissues, OTX1 and p53 gene expression have a correlation coefficient of r ¼ 0.864, significantly different from zero (t ¼ 8.412), with a probability of P ¼ 1.284E À08 (Po0.001**). (c) Formalinfixed, paraffin-embedded section of breast carcinoma showing nuclear localization (brown nuclei) of OTX1 protein. The immunohistochemical analysis was performed with a biotin-free detection system (Ultravision detection system kit, Thermo scientific, Fremont, CA, USA), according to the manufacturer's instructions. Rabbit anti-OTX2 polyclonal antibody (Chemicon International, Temecula, CA, USA, cat. #AB9566) was applied overnight at a dilution of 1/2000. The antibody reacts also with OTX1 due to amino acid sequence homology between the two proteins. As OTX2 mRNA has not been detected in any tumors we can consider that the immunoreactivity was due to the presence of OTX1 protein. Specificity controls consisted of: (i) use of control tissues with or without the pertinent antigen, (ii) omission of the primary antibody and substitution with non-immune serum at the same dilution (DAB-Haematoxylin, scale bar 40 mm). 
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A Terrinoni et al core and matrix similarity above 0.8. The 'in silico' analysis showed the presence of two putative p53 responsive elements (RE). The first is located at À3435 bp from the ATG (p53RE-5 0 ), with matrix similarity of 0.942 and core similarity of 0.921. The second is located at þ 1268 bp from the ATG into the second intron, with matrix similarity of 0.898 and a core similarity of 1.0.
In order to understand if one of these two putative RE sites represented a functional p53-binding site, a chromatin immunoprecipitation analysis was carried out (Figure 2d ). SaOs2 p53 Tet-On cells, treated and untreated with doxycyclin at 12 and 24 h were immunoprecipitated using an anti-p53 antibody and non-specific IgG as control. Two regions approximately of 160-170 bp surrounding the two RE sites were No amplification was obtained for the p53RE-5 0 , even using exhaustive PCR amplification of 40 cycles, indicating that there was no binding of p53 on this site. A positive signal was obtained for the p53RE-3 0 , at 24 h of p53 induction. No signal was obtained from the immunoprecipitation with IgG, indicating the specificity of the recognition by p53 antibody. These results clearly demonstrated the physical interaction between p53 and the OTX1 promoter via 3 0 p53RE. It is interesting that the putative functional p53 RE is located after the transcription-starting site, internal to a transcribed region.
To clarify if the 3 0 p53RE is able to drive the expression of the OTX1 gene, we cloned 1431 bp of the region containing this RE in the pGL3 luciferase basic vector (pGL3-OTX1) to be used as minimal promoter. Luciferase assay was performed by co-transfecting pGL3-OTX1 with increasing amounts of p53 expression vector, from a ratio of 1:1 through to 1:10. The results indicate that this region is able to drive the luciferase transcription, behaving as a minimal promoter. This ability is directly proportional to the increase of p53 expression, confirming also the in vivo data from SaOs2 cells (Figure 2e ).
All these results lead to the conclusion that OTX1 is a target gene for p53, which can regulate its expression through the p53RE-3 0 . Furthermore, to test the interaction of other p53 family members with the OTX1 promoter, we performed a luc-assay experiment using the alpha isoforms of both TA/DeltaNp63, and p73. We found that both were able to transactivate the OTX1 promoter, albeit at lower levels than p53 (Melino et al., 2003; MurrayZmijewski et al., 2006) (Figure 4a) .
In order to investigate the molecular interaction between OTX1 and p53 during cell differentiation, LA7 CSCs were studied. qRT-PCR was performed on cDNA obtained from LA7 and LA7 induced to differentiate with DMSO (LA7D) (Zucchi et al., 2008) , and we detected increased levels both of p53 and OTX1 in LA7D, implying a role of these genes in the asymmetric division of CSCs (Figure 3a) . LA7D showed increased immunohistochemical OTX1 positivity in comparison with non-induced LA7 (data not shown).
We also demonstrated changes in OTX1 gene expression levels in mice during mammary gland development (Figure 3b) . RNAs from breast tissue of virgin, pregnant and lactating mice were retro-transcribed and the cDNAs were analyzed with qRT-PCR. OTX1 presents higher expression levels during lactation, when breast differentiates into ducts and alveoli.
To investigate the possible role of p53 modulation of OTX1 during the physiological breast remodeling in rodent, we evaluated the level of OTX1 in p53 À/À breast tissue in lactation (Jacks et al., 1994) Our results showed the presence of OTX1 gene expression also in p53 deficient mice, demonstrating that although p53 could drive the expression of OTX1 in cancer breast cells, it is not involved in the physiological tissue remodeling during lactation (Figure 4b ).
Discussion
Breast cancer, one of the most common and feared cancers, rank second after lung cancer among tumorrelated deaths (Ries et al., 2000) . Indeed, one out of nine women are affected by breast cancer at some stage in life. The direct control of the tumor suppressor p53 over the OTX1 homeobox gene raises the question on the functional role of this interaction in tumors. Although p53 has initially been studied for its tumor suppressor function, recently it has been proposed as a central molecule in the differentiation of CSCs (Cicalese et al., 2009 ). OTX1 has been described as a critical molecule for axon refinement in developing cerebral cortex, and the developmental role of the OTX family genes have (lower panel) proteins were analyzed in the doxycycline inducible Tet-On/p53-SaOs2 cell line after 12, 24 and 48 h. The p53 and OTX1 protein levels were detected with specific antibodies. Beta-actin was used as a loading control. Primary antibodies were: monoclonal anti-OTX1 (ab58238 Abcam, Cambridge, UK, 1:200) and polyclonal anti-p53 (DO-1, catalog SC-126, Santa Cruz Biotechnology, Santa Cruz, CA, USA, 1:500). Western blotting was performed according to standard procedures. (b) Quantitative real-time reverse transcriptase PCR (qRT-PCR) shows increased levels of the OTX1 expression in Tet-On/p53-SaOs2 inducible cell line treated with doxycycline for 12 and 24 h (at this time OTX mRNA expression reach the plateau). Cells not induced (Dox0 h) were used as control, and beta-actin was used as internal standard for 2 DDCt calculations. SaOs2-inducible cells were treated as previously described (Gressner et al., 2005) . (c) OTX1 promoter analysis. The OTX1 gene structure shows the promoter carrying two putative p53 responsive elements (REs): 5 0 p53 RE (À3435 bp from the ATG) and 3 0 p53 RE ( þ 1268 bp from the ATG). In silico analysis has been performed using Genomatix MatInspector software (Genomatix Software GmbH, Mu¨nchen, Germany). (d) Chromatin immunoprecipitation analysis of the OTX1 promoter. Samples were assayed for the presence of 5 0 p53 RE (left panels) or the 3 0 p53 RE (right panels) of the OTX1 promoter using chromatin from SaOs2-p53TetON, untreated (0 h) or 12 and 24 h Dox-induced. Immunoprecipitation was carried out using p53 specific antibody (upper panels) or IgG-unspecific antibody (lower panels). Signal is only detectable in the sample at 24 h p53-induced cells, confirming a physical interaction between p53 and OTX1 promoter. 12 Â 10 6 cells were cross-linked and used for Chromatin immunoprecipitation analysis accordingly (Candi et al., 2006) . (e) Schematic representation of luciferase reporter plasmid regulated by the putative OTX1 promoter (left). Transiently co-transfected SaOs2 cells were lysed 24 h after transfection and subjected to determination of luciferase activity, according to Promega Dual-Luciferase Reporter Assay System (E1910) (Promega Corporation, Madison, WI, USA) instructions. The graph clearly shows an increase of luciferase activity when increasing amounts of p53 expression vector are transfected (ratio 1:3; 1:5 and 1:10), in respect to the reporter plasmid. The empty vector has been used as a control. Data are presented as fold of induction over control. Three independent experiments were performed (mean þ /Às.d., n ¼ 3) (right).
been well established in murine brain (Acampora et al., 1996; Larsen et al., 2010) .
The role of OTX1 could have a synergistic function with p53 in the differentiation of CSCs in breast cancer. Adult tissues like breast, colon and blood are maintained by proliferation of tissue SCs and the same seems to apply to the tumors that originate from these tissues.
SCs are defined for their ability to make more SCs (self-renewal), as well as to produce cells able to differentiate. The balance between these two processes is determined in embryos and in adult tissues through the switch between asymmetric and symmetric cell divisions. Most SCs can divide either by asymmetric or symmetric division and the balance between these two models is modulated according to developmental and environmental signals (Morrison and Kimble, 2006) . Recent evidence suggests that symmetrical division is necessary for neoplasia proliferation and that asymmetric division is a mechanism of tumor suppression in drosophila neuroblasts (Gonzales, 2007) . Recently, p53 has been shown to regulate the polarity of cell division in mammary gland and its loss of function leads to symmetrical division resulting in tumor growth (Cicalese et al., 2009) . In order to verify the interaction between p53 and OTX1 in CSC differentiation, LA7 and LA7D cells were tested for p53 and OTX1 gene expression, and we found higher levels for both genes in the differentiated cells. These data suggest that p53 and OTX1 overexpression represent an attempt to force the neoplastic cells to differentiate and this raises the hypothesis that OTX1 could be involved in the balance between symmetrical and asymmetrical cells division.
Our study provides evidence that p53 controls OTX1 in tumors and that both genes are co-expressed during the differentiation of breast cancer cells. OTX1 and p53 are expressed during the embryonic development when cells are subjected to rapid cell division and they are switched on again in breast cancer cells, suggesting that their interaction could be involved in CSC (Zucchi et al., 2007) recently sub-cloned, was cultured in undifferentiating condition using Dulbecco's modified Eagle's medium. For differentiation experiments in adherent cultures, LA7 cells were grown at confluence and exposed to 1.8% dimethylsulfoxide for 48 h. Cells were then harvested in trizol for RNA isolation. (b) Changes in OTX1 gene expression levels in mice during linear and cyclical breast development. RNA from breast tissue of virgin, pregnant and lactating CD1 mice have been retro-transcribed and the cDNA have been analyzed with real-time PCR. During lactation, when cells are differentiating into ductal-alveolar architecture, OTX1 shows higher expression levels, indicating its function in normal breast stem cell differentiation. CD1 mice were from the Charles River Laboratories (Wilmington, MA, USA). Mice were maintained in accordance with the Italian Ministry of Health and European Community guidelines. Expression studies were performed on two representative mice. All mice were deeply anesthetized and killed at 1 month and 8 months of age, and after 2 weeks of gestation, as well as 2 weeks of lactation. Mammary gland tissue was preserved in RNA later (Ambion, c/o Applied Biosystems, Foster City, CA, USA) until RNA extraction. differentiation as a tumor suppression mechanism. The OTX1 nuclear and/or cytoplasmic localization suggest different functions of this molecule in cell differentiation (Zhang et al., 2002; Omodei et al., 2009) . Additional data show different OTX1 gene expression levels in mice breast tissues during the linear and the cyclical organ phases, suggesting its function in normal stem cell differentiation. In p53 deficient mice, both lactation and involution appeared normal (Blackburn and Jerry, 2002) . Our studies on p53 À/À breast tissue in lactation show the presence of OTX1 expression independent from p53, implying the function of other transcription factors in OTX1 regulation. Indeed, p63 and p73 members of the p53 family are expressed in p53 À/À breast tissue, and our luc-assay experiments show their involvement in OTX1 regulation, in agreement with other studies (Melino et al., 2003; Murray-Zmijewski et al., 2006) .
The significance of this work lies on the unexpected p53 control over the OTX1 gene expression only in CSCs and not in mammary gland physiological remodeling.
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